Download Citation
Article Source:
Interleukin-17-positive mast cells influence outcomes from BCG for patients with CIS: Data from a comprehensive characterisation of the immune microenvironment of urothelial bladder cancer
Dowell AC,
Cobby E,
Wen K,
Devall AJ,
During V,
et al.
(2017)
Interleukin-17-positive mast cells influence outcomes from BCG for patients with CIS: Data from a comprehensive characterisation of the immune microenvironment of urothelial bladder cancer.
PLOS ONE 12(9): e0184841.
https://doi.org/10.1371/journal.pone.0184841